The Recce Pharmaceuticals Ltd (ASX: RCE) share price has been a positive performer on Tuesday.
In morning trade, the pharmaceutical company’s shares are up 3.5% to $1.17.
This latest gain means the Recce Pharmaceuticals share price has now almost tripled in value over the last 12 months.
Why is the Recce Pharmaceuticals share price storming higher?
Investors have been buying Recce Pharmaceuticals shares this morning following the release of an update on its Recce 327 (R327) product.
According to the release, R327 has demonstrated bactericidal activity against all six antibiotic resistant ESKAPE pathogens. This includes drug resistant mutations (superbugs), as well as two additional World Health Organisation (WHO) priority…